|
PPP4R2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44888570427793E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.87919951505955E-10 |
| Normal-vs-Stage2 |
3.78130000000532E-06 |
| Normal-vs-Stage3 |
2.41690001345773E-10 |
| Normal-vs-Stage4 |
5.81799997068089E-09 |
| Stage1-vs-Stage2 |
9.328600E-01 |
| Stage1-vs-Stage3 |
2.057800E-01 |
| Stage1-vs-Stage4 |
1.822410E-01 |
| Stage2-vs-Stage3 |
4.267000E-01 |
| Stage2-vs-Stage4 |
3.029200E-01 |
| Stage3-vs-Stage4 |
7.191200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78560499719538E-11 |
| Normal-vs-AfricanAmerican |
2.804500E-03 |
| Normal-vs-Asian |
1.59169999958131E-07 |
| Caucasian-vs-AfricanAmerican |
2.769200E-01 |
| Caucasian-vs-Asian |
5.990000E-01 |
| AfricanAmerican-vs-Asian |
1.895040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.54505313993059E-12 |
| Normal-vs-Female |
1.95209959308329E-10 |
| Male-vs-Female |
8.233600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.45639999452152E-08 |
| Normal-vs-Age(41-60Yrs) |
3.61509711055419E-11 |
| Normal-vs-Age(61-80Yrs) |
2.00259997473751E-09 |
| Normal-vs-Age(81-100Yrs) |
4.419100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.258800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.985800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.714800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.767200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.415200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.490600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.211640E-01 |
| Classical-VS-Follicular |
3.412200E-02 |
| Classical-VS-Other |
1.390410E-01 |
| Classical-VS-Normal |
1.97960003944786E-09 |
| Tall-VS-Follicular |
8.923200E-01 |
| Tall-VS-Other |
4.473800E-01 |
| Tall-VS-Normal |
1.04359999975046E-07 |
| Follicular-VS-Other |
4.762000E-01 |
| Follicular-VS-Normal |
2.16160001009769E-09 |
| Other-VS-Normal |
1.062310E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.25760521388452E-11 |
| Normal-vs-N1 |
2.34110000274512E-08 |
| N0-vs-N1 |
4.294600E-01 |
|
|
